Quantum dots facilitate a leap into alternative energy

| | Health Imaging | Molecular Imaging

The semiconductor photocatalysts known in molecular imaging as "quantum dots" are now being used for something completely different: alternative energy. The nanocrystals, instead of highlighting tissues, are harnessing methanol through a process of photosynthesis. This and other research, including advances in biomedical 3D printing and oncologic iron-based MRI contrast agents are featured in a profile of new research published in the New York Academy of Sciences magazine.

A region on the verge of discovery

Related Content

New PET method combines antibody with radioactive isotope to improve lung cancer detection
ALS drug repurposed for PET imaging
New radiotracer has 'incredible potential' to improve management of spinal cord injuries
Frontotemporal dementia often misdiagnosed due to misinterpretations of imaging
Endometriosis imaging agent impresses at clinical trials
Experts say one radiotracer outperforms all others when it comes to detecting prostate cancer

Around the web

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.